David K. Imagawa

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Zeljka Jutric · 3 shared papers, 2023–2026 · strength 0.69
   • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
   • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
   • Paper Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy … DOI 10.1007/s13304-022-01404-4↗
2. Farshid Dayyani · 2 shared papers, 2025–2026 · strength 0.53
   • Paper Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. DOI 10.1016/j.jvir.2026.108954↗
   • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
3. Nadine Abi‐Jaoudeh · 1 shared paper, 2026 · strength 0.29
   • Paper Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. DOI 10.1016/j.jvir.2026.108954↗
4. Jennifer Brooke Goldstein · 1 shared paper, 2026 · strength 0.29
   • Paper Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. DOI 10.1016/j.jvir.2026.108954↗
5. Fa-Chyi Lee · 1 shared paper, 2026 · strength 0.29
   • Paper Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. DOI 10.1016/j.jvir.2026.108954↗
6. Ricardo Azevedo · 1 shared paper, 2026 · strength 0.29
   • Paper Outcomes of Irreversible Electroporation for Treatment of Refractory Locally Advanced Pancreatic Cancer. DOI 10.1016/j.jvir.2026.108954↗
7. Jennifer Brooke Valerin · 1 shared paper, 2025 · strength 0.25
   • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
8. Steven Neema Seyedin · 1 shared paper, 2025 · strength 0.25
   • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
9. Garrett K. Harada · 1 shared paper, 2025 · strength 0.25
   • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
10. David S. Hong · 1 shared paper, 2025 · strength 0.25
    • Paper Predicting Benefit of Neoadjuvant Chemotherapy and Elective Nodal Irradiation in Pancreatic Adenocarcinoma: A Supervise… DOI 10.1002/cam4.71447↗
11. Oliver Gene McDonald · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
12. Nikki K. Lytle · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
13. Christopher J. Halbrook · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
14. Nina G. Steele · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
15. Austin D. Silva · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
16. Rima Singh · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
17. Ian M. Loveless · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
18. Mohammed Aldakkak · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
19. Alica K. Michels · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
20. Jennifer P. Morton · 1 shared paper, 2026 · strength 0.23
    • Paper Comparative Analysis of Primary and Liver Fibroblasts Reveals MET as a Potent Target in Pancreatic Cancer Metastasis. DOI 10.1016/j.jcmgh.2026.101872↗
21. Ronald Wolf · 1 shared paper, 2023 · strength 0.22
    • Paper Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy … DOI 10.1007/s13304-022-01404-4↗
22. Oscar Hernandez Dominguez · 1 shared paper, 2023 · strength 0.22
    • Paper Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy … DOI 10.1007/s13304-022-01404-4↗
23. Michael David Sgroi · 1 shared paper, 2015 · strength 0.06
    • Paper Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma. DOI 10.1016/j.jvs.2014.09.003↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.